Cargando…

Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy

Background: Although several treatments are currently available for chronic pelvic pain, 30–60% of patients do not respond to them. Therefore, these therapeutic options require a better understanding of the mechanisms underlying endometriosis-induced pain. This study focuses on pain management after...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Augusto, Herrero-Trujillano, Manuel, Vaquero, Gema, Fuentes, Lucia, Gonzalez, Sofia, Mendiola, Agustin, Perez-Medina, Tirso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779548/
https://www.ncbi.nlm.nih.gov/pubmed/35055416
http://dx.doi.org/10.3390/jpm12010101
_version_ 1784637604277256192
author Pereira, Augusto
Herrero-Trujillano, Manuel
Vaquero, Gema
Fuentes, Lucia
Gonzalez, Sofia
Mendiola, Agustin
Perez-Medina, Tirso
author_facet Pereira, Augusto
Herrero-Trujillano, Manuel
Vaquero, Gema
Fuentes, Lucia
Gonzalez, Sofia
Mendiola, Agustin
Perez-Medina, Tirso
author_sort Pereira, Augusto
collection PubMed
description Background: Although several treatments are currently available for chronic pelvic pain, 30–60% of patients do not respond to them. Therefore, these therapeutic options require a better understanding of the mechanisms underlying endometriosis-induced pain. This study focuses on pain management after failure of conventional therapy. Methods: We reviewed clinical data from 46 patients with endometriosis and chronic pelvic pain unresponsive to conventional therapies at Puerta de Hierro University Hospital Madrid, Spain from 2018 to 2021. Demographic data, clinical and exploratory findings, treatment received, and outcomes were collected. Results: Median age was 41.5 years, and median pain intensity was VAS: 7.8/10. Nociceptive pain and neuropathic pain were identified in 98% and 70% of patients, respectively. The most common symptom was abdominal pain (78.2%) followed by pain with sexual intercourse (65.2%), rectal pain (52.1%), and urologic pain (36.9%). A total of 43% of patients responded to treatment with neuromodulators. Combined therapies for myofascial pain syndrome, as well as treatment of visceral pain with inferior or superior hypogastric plexus blocks, proved to be very beneficial. S3 pulsed radiofrequency (PRF) plus inferior hypogastric plexus block or botulinum toxin enabled us to prolong response time by more than 3.5 months. Conclusion: Treatment of the unresponsive patient should be interdisciplinary. Depending on the history and exploratory findings, therapy should preferably be combined with neuromodulators, myofascial pain therapies, and S3 PRF plus inferior hypogastric plexus blockade.
format Online
Article
Text
id pubmed-8779548
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87795482022-01-22 Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy Pereira, Augusto Herrero-Trujillano, Manuel Vaquero, Gema Fuentes, Lucia Gonzalez, Sofia Mendiola, Agustin Perez-Medina, Tirso J Pers Med Article Background: Although several treatments are currently available for chronic pelvic pain, 30–60% of patients do not respond to them. Therefore, these therapeutic options require a better understanding of the mechanisms underlying endometriosis-induced pain. This study focuses on pain management after failure of conventional therapy. Methods: We reviewed clinical data from 46 patients with endometriosis and chronic pelvic pain unresponsive to conventional therapies at Puerta de Hierro University Hospital Madrid, Spain from 2018 to 2021. Demographic data, clinical and exploratory findings, treatment received, and outcomes were collected. Results: Median age was 41.5 years, and median pain intensity was VAS: 7.8/10. Nociceptive pain and neuropathic pain were identified in 98% and 70% of patients, respectively. The most common symptom was abdominal pain (78.2%) followed by pain with sexual intercourse (65.2%), rectal pain (52.1%), and urologic pain (36.9%). A total of 43% of patients responded to treatment with neuromodulators. Combined therapies for myofascial pain syndrome, as well as treatment of visceral pain with inferior or superior hypogastric plexus blocks, proved to be very beneficial. S3 pulsed radiofrequency (PRF) plus inferior hypogastric plexus block or botulinum toxin enabled us to prolong response time by more than 3.5 months. Conclusion: Treatment of the unresponsive patient should be interdisciplinary. Depending on the history and exploratory findings, therapy should preferably be combined with neuromodulators, myofascial pain therapies, and S3 PRF plus inferior hypogastric plexus blockade. MDPI 2022-01-13 /pmc/articles/PMC8779548/ /pubmed/35055416 http://dx.doi.org/10.3390/jpm12010101 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pereira, Augusto
Herrero-Trujillano, Manuel
Vaquero, Gema
Fuentes, Lucia
Gonzalez, Sofia
Mendiola, Agustin
Perez-Medina, Tirso
Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title_full Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title_fullStr Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title_full_unstemmed Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title_short Clinical Management of Chronic Pelvic Pain in Endometriosis Unresponsive to Conventional Therapy
title_sort clinical management of chronic pelvic pain in endometriosis unresponsive to conventional therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779548/
https://www.ncbi.nlm.nih.gov/pubmed/35055416
http://dx.doi.org/10.3390/jpm12010101
work_keys_str_mv AT pereiraaugusto clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT herrerotrujillanomanuel clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT vaquerogema clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT fuenteslucia clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT gonzalezsofia clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT mendiolaagustin clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy
AT perezmedinatirso clinicalmanagementofchronicpelvicpaininendometriosisunresponsivetoconventionaltherapy